Formosa Pharmaceuticals, Inc. (TWSE: 6838)
Health Care · Pharmaceuticals · TW
NT$23.20
+0.87% today · -29.4% 1Y
Formosa Pharmaceuticals, Inc. (TWSE: 6838) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $110.00M.
Over the last twelve months the share price has lost 29.4%, trading between 22.35 and 34.00.
Tweenvest scores Formosa Pharmaceuticals, Inc. across four factors: quality 32/100, value 48/100. Its strongest factor is value.
6838 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $110.00M
- Revenue (TTM)
- $1.65M
- P/E
- —
- EPS
- -1.25
- Dividend yield
- —
- Beta (5Y)
- 0.64
- 52-week high
- NT$34.00
- 52-week low
- NT$22.35
- Avg volume (3M)
- —
- Shares outstanding
- 150.98M
- Employees
- —
- Next earnings
- —
About Formosa Pharmaceuticals, Inc.
Formosa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan. It is involved in developing TSY-110, an antibody-drug conjugate; and TSY-0210, an antibiotic for drug resistant infections. The company also develops APP13002 to treat infectious eye diseases, such as conjunctivitis, keratitis, blepharitis, and meibomian gland dysfunction; and MPT0E028, a novel pan- histone deacetylase inhibitor for solid tumors, such as hepatomas and colorectal cancer. It has a strategic partnership with Eyenovia, Inc. for the development of novel ophthalmic therapeutic; and Singapore Eye Research Institute to develop ophthalmic formulations for corneal diseases. Formosa Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Taipei City, Taiwan.
- ISIN
- TW0006838006
- Founded
- 2010
- Listed since
- Oct 7, 2021
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,213.74 | -1.61% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.87 | -0.83% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $154.50 | -1.25% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.90 | -1.04% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.60 | -1.73% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.29 | -0.98% |
Figures last refreshed Aug 18, 2026.